                               SEQUENCE LISTING

<110> BOSTON, JUDITH
 
<120> TREATING OPHTHALMIC DISEASE USING HYPOXIA-INDUCIBLE FACTOR 
      INHIBITORS

<130> B3763.10002US02

<140>
<141>

<150> 16/371,398
<151> 2019-04-01

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Cys Leu Leu Phe Val Tyr 
1               5       


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Glu Lys Tyr Glu Leu Asp 
1               5           


<210> 3
<211> 56
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Val Leu Phe Tyr Val Tyr Pro Val Arg Cys Glu Trp Cys Glu Phe Leu 
1               5                   10                  15      


Thr Cys Ile Pro Phe Thr Asp Lys Phe Cys Glu Lys Tyr Glu Leu Asp 
            20                  25                  30          


Ala Gln Leu His Glu Ser Gly Gly Gly Gly Ser Pro Gly Arg Arg Arg 
        35                  40                  45              


Arg Arg Arg Arg Arg Arg Arg Arg 
    50                  55      


<210> 4
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Glu Ser Gly Gly Gly Gly Ser Pro Gly Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg Arg Arg Arg 
            20  


<210> 5
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Val Leu Phe Tyr Val Tyr Pro Val Arg Cys Glu Trp Cys Glu Phe Leu 
1               5                   10                  15      


Thr Cys Ile Pro Phe Thr Asp Lys Phe Cys Glu Lys Tyr Glu Leu Asp 
            20                  25                  30          


Ala Gln Leu His 
        35      


<210> 6
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Thr Asp Lys Phe Cys Glu Lys Tyr Glu Leu Asp Ala Gln Leu His Glu 
1               5                   10                  15      


Ser Gly Gly Gly Gly Ser Pro Gly Arg Arg Arg Arg Arg Arg Arg Arg 
            20                  25                  30          


Arg Arg Arg 
        35  


<210> 7
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Glu Lys Tyr Glu Leu Asp Glu Ser Gly Gly Gly Gly Ser Pro Gly 
1               5                   10                  15      


Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
            20                  25          


<210> 8
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Asp Trp Phe Lys Ala Phe Tyr Asp Lys Val Ala Glu Lys Phe Lys Glu 
1               5                   10                  15      


Ala Phe 
        


